Trends in management of ureteral urothelial carcinoma and effects on survival: a hospital-based registry study.

CONCLUSION: Our study suggests that SU may be an appropriate alternative to NU for the management of high-risk ureteral tumors. Further, lymphadenectomy may play an important role at the time of NU, and adjuvant chemotherapy is infrequently utilized in patients with advanced pathology.
PMID: 33012575 [PubMed - as supplied by publisher]

Source: Urologic Oncology - September 30, 2020 Category: Urology & Nephrology Authors: Lec PM, Venkataramana A, Lenis AT, Fero KE, Sharma V, Golla V, Gollapudi K, Blumberg J, Chamie K Tags: Urol Oncol Source Type: research